Leading healthcare organizations are sounding the alarm over a severe shortage of cancer therapies, leaving thousands of patients without life-saving treatments. US regulators have listed 14 oncology medicines, including the generic chemotherapy drugs cisplatin and carboplatin, as in shortage. Hospitals have already started rationing some drugs, forcing doctors to make difficult decisions about delaying chemotherapy treatment or using substitute medicines that may not be as effective. The concern is that substitute drugs may reduce the probability of a cure, says the American Society of Clinical Oncology’s Julie Gralow. Between 100,000 and 500,000 patients could reportedly be affected by shortages of cisplatin and carboplatin, highlighting the urgent need for policymakers to strengthen supply chains.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
